Page last updated: 2024-08-25

nobiletin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

nobiletin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, PY; Chin, HK; Chuang, CH; Lin, CY; Wu, MJ; Yen, JH1
Ikegawa, T; Koyabu, N; Morimoto, S; Naito, M; Ohtani, H; Sawada, Y; Shoyama, Y; Tsuruo, T; Ushigome, F1

Other Studies

2 other study(ies) available for nobiletin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
    Cells, 2020, 04-03, Volume: 9, Issue:4

    Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Differentiation; Cell Nucleus; Cell Proliferation; Early Growth Response Protein 1; Flavones; Gene Expression Regulation, Leukemic; Gene Ontology; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Megakaryocytes; RNA, Messenger; Up-Regulation

2020
Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.
    Cancer letters, 2000, Nov-10, Volume: 160, Issue:1

    Topics: Acetates; ATP Binding Cassette Transporter, Subfamily B; Beverages; Blotting, Western; Citrus; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavones; Flavonoids; Furocoumarins; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Plant Extracts; Tritium; Verapamil; Vincristine

2000